4mn3
From Proteopedia
(Difference between revisions)
| Line 8: | Line 8: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4mn3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4mn3 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4mn3 RCSB], [http://www.ebi.ac.uk/pdbsum/4mn3 PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4mn3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4mn3 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4mn3 RCSB], [http://www.ebi.ac.uk/pdbsum/4mn3 PDBsum]</span></td></tr> | ||
</table> | </table> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/CBX7_HUMAN CBX7_HUMAN]] Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility. Promotes histone H3 trimethylation at 'Lys-9' (H3K9me3). Binds to trimethylated lysine residues in histones, and possibly also other proteins. Regulator of cellular lifespan by maintaining the repression of CDKN2A, but not by inducing telomerase activity.<ref>PMID:19636380</ref> <ref>PMID:21060834</ref> <ref>PMID:21282530</ref> <ref>PMID:21047797</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 21: | Line 23: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
| - | [[Category: Boulanger, M J | + | [[Category: Boulanger, M J]] |
| - | [[Category: Chakravarthi, S | + | [[Category: Chakravarthi, S]] |
| - | [[Category: Daze, K | + | [[Category: Daze, K]] |
| - | [[Category: Dev, A | + | [[Category: Dev, A]] |
| - | [[Category: Douglas, S | + | [[Category: Douglas, S]] |
| - | [[Category: Heller, M | + | [[Category: Heller, M]] |
| - | [[Category: Hof, F | + | [[Category: Hof, F]] |
| - | [[Category: Peng, F | + | [[Category: Peng, F]] |
| - | [[Category: Quon, T | + | [[Category: Quon, T]] |
| - | [[Category: Wulff, J | + | [[Category: Wulff, J]] |
[[Category: Chromobox domain 7]] | [[Category: Chromobox domain 7]] | ||
[[Category: Transcription regulator]] | [[Category: Transcription regulator]] | ||
Revision as of 04:58, 25 December 2014
Chromodomain antagonists that target the polycomb-group methyllysine reader protein Chromobox homolog 7 (CBX7)
| |||||||||||
Categories: Human | Boulanger, M J | Chakravarthi, S | Daze, K | Dev, A | Douglas, S | Heller, M | Hof, F | Peng, F | Quon, T | Wulff, J | Chromobox domain 7 | Transcription regulator
